Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy.
Christoph HenkenberensAnn-Kathrin OehusThorsten DerlinFrank BengelTobias L RossMarkus A KuczykStefan JanssenHans ChristiansenChristoph A J von KlotPublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2020)
If patients are followed up closely, including PSMA PET scans, a second PSMA PET-directed RT represents a viable treatment option for well-informed and well-selected patients.
Keyphrases
- pet ct
- prostate cancer
- pet imaging
- end stage renal disease
- computed tomography
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- positron emission tomography
- radiation therapy
- squamous cell carcinoma
- stem cells
- radical prostatectomy
- magnetic resonance imaging
- magnetic resonance
- bone marrow
- rectal cancer
- radiation induced